These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8582907)

  • 1. A study of reversibly inactivated lipases for use in a morphine-triggered naltrexone delivery system.
    Nakayama GR; Roskos KV; Fritzinger BK; Heller J
    J Biomed Mater Res; 1995 Nov; 29(11):1389-96. PubMed ID: 8582907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of lipase on the release of naltrexone from triglyceride-coated cellulose acetate phthalate microspheres.
    Tefft JA; Roskos KV; Heller J
    J Biomed Mater Res; 1992 Jun; 26(6):713-24. PubMed ID: 1527096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved long-acting delivery system for narcotic antagonists.
    Misra AL; Pontani RB
    NIDA Res Monogr; 1981; 28():254-64. PubMed ID: 6791009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of drug delivery systems for use in treatment of narcotic addiction.
    Sharon AC; Wise DL
    NIDA Res Monogr; 1981; 28():194-213. PubMed ID: 6791005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A morphine-triggered delivery system useful in the treatment of heroin addiction.
    Roskos KV; Tefft JA; Heller J
    Clin Mater; 1993; 13(1-4):109-19. PubMed ID: 10146246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum naltrexone and 6-beta-naltrexol levels from naltrexone implants can block very large amounts of heroin: a report of two cases.
    Brewer C
    Addict Biol; 2002 Jul; 7(3):321-3. PubMed ID: 12126492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone microspheres: in vitro release and effect on morphine analgesia in mice.
    He GA; Hou HM; Liu XJ
    Acta Pharmacol Sin; 2001 Jun; 22(6):530-3. PubMed ID: 11747760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological evaluation of narcotic antagonist delivery systems in rhesus monkeys.
    Harrigan SE; Downs DA
    NIDA Res Monogr; 1981; 28():77-92. PubMed ID: 6791015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of synthetic polypeptides in the preparation of biodegradable delivery vehicles for narcotic antagonists.
    Sidman KR; Arnold DL; Steber WD; Nelsen L; Granchelli FE; Strong P; Sheth SG
    Natl Inst Drug Abuse Res Monogr Ser; 1976 Jan; (4):33-8. PubMed ID: 967233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of irreversible antagonists to determine the relative efficacy of mu-opioids in a pigeon drug discrimination procedure: comparison of beta-funaltrexamine and clocinnamox.
    Barrett AC; Smith ES; Picker MJ
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1061-70. PubMed ID: 12649297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of chronic prenatal and postnatal administration of naltrexone in locomotor activity induced by morphine in mice.
    Medina Jiménez M; Luján Estrada M; Rodríguez R
    Arch Med Res; 1997; 28(1):61-5. PubMed ID: 9078589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of polylactic/glycolic acid delivery systems for use in treatment of narcotic addiction.
    Schwope AD; Wise DL; Howes JF
    Natl Inst Drug Abuse Res Monogr Ser; 1976 Jan; (4):13-8. PubMed ID: 787798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists.
    Miller DK; Lever JR; Rodvelt KR; Baskett JA; Will MJ; Kracke GR
    Drug Alcohol Depend; 2007 Jul; 89(2-3):282-91. PubMed ID: 17368966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of repeated administration of a new oral naltrexone controlled-release system on morphine analgesia.
    Alvarez-Fuentes J; Rojas -Corrales MO; Holgado MA; Sánchez-Lafuente C; Micó JA; Fernández -Arévalo M
    J Pharm Pharmacol; 2001 Sep; 53(9):1201-5. PubMed ID: 11578102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine upregulates functional expression of neurokinin-1 receptor in neurons.
    Wan Q; Douglas SD; Wang X; Kolson DL; O'Donnell LA; Ho WZ
    J Neurosci Res; 2006 Nov; 84(7):1588-96. PubMed ID: 16983662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultra-low dose naltrexone potentiates the anticonvulsant effect of low dose morphine on clonic seizures.
    Honar H; Riazi K; Homayoun H; Sadeghipour H; Rashidi N; Ebrahimkhani MR; Mirazi N; Dehpour AR
    Neuroscience; 2004; 129(3):733-42. PubMed ID: 15541894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A duplex "Gemini" prodrug of naltrexone for transdermal delivery.
    Hammell DC; Hamad M; Vaddi HK; Crooks PA; Stinchcomb AL
    J Control Release; 2004 Jun; 97(2):283-90. PubMed ID: 15196755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of injectable microcapsules for use in the treatment of narcotic addiction.
    Thies C
    Natl Inst Drug Abuse Res Monogr Ser; 1976 Jan; (4):19-20. PubMed ID: 967230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of naltrexone hydrochloride and naltrexone glucuronide in the dog].
    Li H; Zhao SF; Wang N; Ge ZH
    Yao Xue Xue Bao; 1996; 31(4):254-7. PubMed ID: 9208648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal signaling activity of mu opioid receptor in mouse brain: role in narcotic dependence.
    Wang D; Raehal KM; Lin ET; Lowery JJ; Kieffer BL; Bilsky EJ; Sadée W
    J Pharmacol Exp Ther; 2004 Feb; 308(2):512-20. PubMed ID: 14600246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.